Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

EDIT reports narrower Q3 loss, boosts revenues on a Bristol Myers milestone, and advances in vivo gene-editing program with ...

Vertex, Inc. (($VERX)) has held its Q3 earnings call. Read on for the main highlights of the call. Vertex, Inc. Earnings Call Reveals Mixed ...

Google Cloud has rolled out a series of updates to its Vertex AI Agent Builder in the hope that developers continue to build, test and deploy AI agents on its platform, with an emphasis on faster ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

Eli Lilly’s star oral GLP-1 candidate orforglipron and Novo Nordisk’s Wegovy (semaglutide) were named voucher winners in a ...

Dennis Dean, Ph.D., appointed as Executive Vice President and Head of Non-Clinical Development at Odyssey Therapeutics.

Google Cloud expanded features of its Agent Builder platform focusing on orchestration, observability and monitoring for the ...

CRISPR Therapeutics CRSP reported a third-quarter 2025 loss of $1.17 per share, narrower than the Zacks Consensus Estimate of ...

With its no-code app builder now widely available, Google is betting that tools like Opal can turn everyday users into AI ...

This Employment Ontario program is funded in part by the Government of Canada and the Government of Ontario. Soldiers in Tech proudly welcomes all Canadian Armed Forces veterans, reservists (minimum ...

Hexaware Technologies (NSE: HEXT), a global provider of IT solutions and services, today announced the launch of two new ...